Introduction
Synovial sarcomas (SS) account for approximately 10% of all soft-tissue sarcomas, and typically arise from the para-articular region in adolescents and young adults, but have no relationship to synovium (Weiss and Goldblum, 2001 ). The origin of SS is uncertain, since the normal cellular counterpart for this tumor is unknown. Some studies support the idea that SS arises from a mesenchymal stem cell with a capacity for epithelial differentiation (Noguchi et al., 1997; Yakushiji et al., 2000) . SS is known to have two major forms. Monophasic tumors, in which the tumors are entirely composed of spindle cells with or without solid epithelial areas, are distinguished from biphasic tumors that contain epithelial cells arranged in glandular formation in a background of spindle cells. SS contains a t(X;18)(p11.2;q11.2) representing the fusion of SYT on the chromosome 18 with either SSX1 or SSX2 (or rarely with SSX4) on the X chromosome (Clark et al., 1994; Crew et al., 1995; Skytting et al., 1999) . It has been shown that almost all of the biphasic tumors contain the SYT--SSX1 fusion, whereas tumors with SYT-SSX2 rarely exhibit biphasic histology . Therefore, it has been suggested that subtle functional differences between SYT-SSX1 and SYT-SSX2 may impact on epithelial differentiation in these sarcomas (Ladanyi, 2001) ; however, this model awaits experimental confirmation.
The cell-cell adhesion molecule E-cadherin has been shown to perform important functions in embryogenesis and tissue architecture by forming intercellular junction complexes and establishing cell polarization (Takeichi, 1991 (Takeichi, , 1993 Overduin et al., 1995; Shapiro et al., 1995; Hirohashi, 1998) . The extracellular domain of E-cadherin acts as a molecular zipper that mediates cell-cell adhesion, whereas the cytoplasmic tail is linked to the actin cytoskeleton via catenins (Ozawa et al., 1990; Kemler, 1993) . It has been suggested that the loss of E-cadherin expression is involved in the invasive and metastatic properties of neoplastic cells (Takeichi, 1991 (Takeichi, , 1993 Mayer et al., 1993; Hirohashi, 1998) . In addition, downregulation of E-cadherin has also been reported to occur during epithelial-mesenchymal transitions, the process of cellular morphological changes in epithelial cells from epithelial features to a more fibroblastic and flattened phenotype (Batlle et al., 2000; Cano et al., 2000; Poser et al., 2001; Savagner, 2001; Blanco et al., 2002; Hajra et al., 2002; Locascio et al., 2002; Nieto, 2002; Rosivatz et al., 2002; Thiery, 2002) .
There are several mechanisms by which E-cadherin function can be impaired. E-cadherin inactivation caused by mutations has been reported in various tumors and cancer cell lines (Oda et al., 1994; Berx et al., 1995; Soares et al., 1997; Guilford et al., 1998; Machado et al., 1999; Saito et al., 1999 Saito et al., , 2001 Endo et al., 2001) . Promoter inactivation attributed to hypermethylation has been observed in human breast, gastric, thyroid, bladder and prostate cancers as well as in certain leukemias (Graff et al., 1995 (Graff et al., , 2000 Hennig et al., 1995; Hiraguchi et al., 1998; Melki et al., 2000; Tamura et al., 2000; Bornman et al., 2001 ). Promoter hypermethylation is by far the predominant mechanism, and gene mutation is very rare except in specific subtypes of breast and gastric cancer.
The Snail family of zinc-finger transcription factors occupies a central role in morphogenesis, as its members are essential for mesoderm formation in several organisms from flies to mammals (Nieto et al., 1994; Sefton et al., 1998; Carver et al., 2001; Nieto, 2002; Thiery, 2002) . Recently, the transcription factor Snail has been shown to be a direct repressor of E-cadherin gene expression by binding to its proximal promoter in epithelial tumor cells (Batlle et al., 2000; Cano et al., 2000) . The Snail family of transcription factors has previously been shown to be expressed in fibroblasts and implicated in the control of epithelial-mesenchymal transitions during embryonic development (Batlle et al., 2000; Cano et al., 2000) . Furthermore, it has also been demonstrated that endogenous Snail proteins are present in invasive human carcinoma cell lines and in tumors in which E-cadherin expression has been lost with associated acquisition of a fibroblastic phenotype (Batlle et al., 2000) . In addition, Snail can mediate significant negative regulation of E-cadherin expression in gastric and breast carcinomas as well as malignant melanoma (Poser et al., 2001; Hajra et al., 2002; Rosivatz et al., 2002) .
Another gene implicated in control of epithelial differentiation, ELF3, is from the ETS family of transcription factors. A large number of genes expressed in the epithelium contain consensus binding sites for ETS transcription factors in their promoter or enhancer regions (Scott et al., 1994; Gambarotta et al., 1996; Rodrigo et al., 1999) . A recent expression profiling study of SS revealed ELF3 (E74-like factor-3), an ets-family transcription factors (Oettgen et al., 1997) , as one of the differentially expressed genes between monophasic and biphasic tumors (Allander et al., 2002) , raising the possibility that ELF3 might have an important role to play in epithelial differentiation of SS, specifically that overexpression of ELF3 might be associated with glandular epithelial differentiation in SS.
Recently, E-cadherin expression has been studied in sarcomas, and found to be largely restricted to SS (Sato et al., 1999; Saito et al., 2000; Laskin and Miettinen, 2002; Yoo et al., 2002) . We recently reported frequent Ecadherin gene mutations in SS and demonstrated the mutational inactivation of E-cadherin as a potential mechanism of spindle cell morphology in SS (Saito et al., 2001) . A putative cause-effect relationship between Ecadherin inactivation and histologic subtype in SS was suggested based on similar observations in specific subtypes of gastric and breast cancers (Berx et al., 1995; Machado et al., 1999) .
As part of our overall effort to better understand epithelial differentiation in SS, we studied possible mechanisms of E-cadherin silencing in SS. We demonstrate here different modes of E-cadherin inactivation in SS, and find that the loss of E-cadherin expression correlates with histologic and molecular diversity in SS.
Results

SYT-SSX fusion type and expression of E-cadherin and ELF3
First, SYT-SSX fusion type in SS was analysed. SYT-SSX1 and SYT-SSX2 fusions were detected in 24 tumors (60%) and 16 tumors (40%), respectively. SYT-SSX fusion type showed the same association with histology previously well described in larger studies . The 24 SYT-SSX1 tumors included 16 monophasic SS and eight biphasic SS, whereas the 16 SYT-SSX2 tumors included 15 monophasic but only one biphasic case (P ¼ 0.06; Fisher's exact test). Next, endogenous E-cadherin and ELF3 expression were examined. E-cadherin mRNA expression was observed in 27 out of 40 cases (67.5%: monophasic, 18/30; biphasic, 9/9; poorly differentiated, 0/1) of SS. ELF3 mRNA expression was observed in 25 out of 40 cases of SS (62.5%: monophasic, 16/30; biphasic, 9/9; poorly differentiated, 0/1), and almost completely correlated with that of E-cadherin (P ¼ 0.0013 by Fisher's exact test; Table 1 , and Figure 1 ). By RT-polymerase chain reaction (PCR), there was no correlation between SYT-SSX fusion type and E-cadherin or ELF3 mRNA expression in SS. These positive RT-PCR results for E-cadherin and ELF3 expression were confirmed to be derived from tumor cells by immunohistochemistry for the former or negative results in corresponding normal tissues where these tissues were available for the latter.
E-cadherin gene mutations in SS with SYT-SSX1 fusion type
We have recently shown that the E-cadherin gene is inactivated in a subset of SS, and that this event might be a determinant of histological features in SS (Saito et al., 2001) . This analysis was extended to the present series of 40 SS cases. Five of the 40 SS cases contained E-cadherin missense mutations (12.5%, Table 1 ). All five SS cases with E-cadherin missense mutations had the SYT-SSX1 fusion transcript (Fisher's exact test; P ¼ 0.07, Table 2 ). SYT-SSX1 are more likely to show biphasic histology than SYT-SSX2 tumors (Ladanyi, 2001 ), but interestingly the five SYT-SSX1 SS cases with 
a SS numbers from Kyushu University are identical to those in the previous paper (Saito et al., 2001) . b MSP: methylation-specific PCR. c Snail exp. level: (Snail/GAPDH) Â 1000 Figure 1 ELF3 and E-cadherin mRNA expression by RT-PCR. Lanes 1-5: synovial sarcoma, lanes 6-10: other spindle cell sarcomas. In SS, ELF3 and E-cadherin expression were completely correlated. In other spindle cell sarcomas, ELF3 expression was detected, but E-cadherin expression was not observed in any of the cases E-cadherin inactivation in synovial sarcomas T Saito et al E-cadherin missense mutations were all monophasic tumors.
Methylation of CpG islands in the E-cadherin promoter region is rare in SS
Next, we investigated the possibility that aberrant methylation of the CpG island flanking the 5 0 transcriptional start site on the E-cadherin gene was responsible for its lack of expression in SS. Promoter hypermethylation of the E-cadherin gene was detected in only five out of 40 cases (12.5%) at least with one of two primer sets (Figure 2a and b). Among five cases with promoter hypermethylation, only one was negative for E-cadherin mRNA expression (Table 1) . Two of the remaining four cases with E-cadherin promoter hypermethylation were of biphasic histology. Methylation status of the Ecadherin gene did not correlate with E-cadherin mRNA expression in SS.
Inverse correlation between E-cadherin expression and Snail expression in SS
First, the correlation between Snail expression level and epithelial-related gene (E-cadherin or ELF3) expression in SS was examined. When SS were divided into two groups according to epithelial gene mRNA expression (E-cadherin or ELF3), E-cadherin-positive SS cases showed statistically significant lower Snail expression than negative cases (Figure 3 , P ¼ 0.027, Mann-Whitney's U-test). However, there were no significant correlations between the histologic subtype (biphasic vs others) and Snail expression, or between SYT-SSX fusion type and Snail expression in SS (P ¼ 0.29 and P ¼ 0.98, respectively).
Correlation of E-cadherin membranous expression with SYT-SSX1 fusion type and biphasic histology in SS E-cadherin membranous staining was observed immunohistochemically in 14 of 40 SS cases (35.0%: monophasic fibrous, 5/30; biphasic, 9/9; poorly differentiated, 0/1). Some cases showed not membranous but nuclear expression of E-cadherin. E-cadherin membranous expression correlated with biphasic histology in SS (Po0.0001). In addition, E-cadherin membranous expression correlated with SYT-SSX1 fusion type (Table 3 ; P ¼ 0.02 by Fisher's exact test), as might be expected given the association of SYT-SSX fusion type and histology. There was no correlation between E-cadherin membranous expression and Snail mRNA expression level (P ¼ 0.27).
Higher expression of ELF3 in biphasic SS compared to monophasic SS
To independently validate previous cDNA microarray data that first identified the preferential expression of ELF3 in biphasic tumors (Allander et al., 2002) , quantitative real-time RT-PCR for ELF3 was performed using a separate set of 73 cases of SS. This revealed that ELF3 was more highly expressed in Figure 4 ). However, there was no correlation between SYT-SSX fusion type and ELF3 expression level.
Discussion
Reduced E-cadherin expression has been shown to cause cellular morphological changes in epithelial cells, resulting in a more fibroblastic and flattened phenotype (Frixen et al., 1991; Vleminckx et al., 1991; Batlle et al., 2000; Cano et al., 2000; Poser et al., 2001; Savagner, 2001; Blanco et al., 2002; Hajra et al., 2002; Locascio et al., 2002; Nieto, 2002; Rosivatz et al., 2002; Thiery, 2002) . Recent reports have demonstrated E-cadherin expression in some sarcomas, mainly SS, particularly in the glandular structures of biphasic SS (Sato et al., 1999; Saito et al., 2000; Laskin and Miettinen, 2002; Yoo et al., 2002) . The spindle cell component of SS often shows histological features that closely resemble those of other spindle cell sarcomas such as MFH, LMS and MSNST, although spindle cell sarcomas other than SS rarely exhibit morphological epithelial differentiation. We recently identified mutational inactivation of E-cadherin as a correlate of spindle cell morphology in SS (Saito et al., 2001) . These findings suggested the hypothesis that the silencing of epithelial-related genes, such as the E-cadherin gene, may be responsible for the acquisition or maintenance of the spindle cell morphology in SS. ELF3 was recently identified as one of the genes differentially expressed between monophasic and biphasic SS (Allander et al., 2002) . A large number of genes expressed in diverse epithelia are known to contain consensus binding sites for ETS transcription factors in their promoter or enhancer regions, including E-cadherin (Scott et al., 1994; Gambarotta et al., 1996; Rodrigo et al., 1999) . Therefore, we examined E-cadherin and ELF3 expression in SS to evaluate their correlates. As expected, E-cadherin expression was almost completely correlated with that of ELF3 in SS. E-cadherin was confirmed by immunohistochemistry to be expressed in the tumor cells of SS with E-cadherin transcripts. However, we could not confirm the histologic distribution of ELF3 in SS, because an antibody to ELF3 currently is not available. Therefore, it remains formally possible that the ELF3 transcripts detected in SS are derived from non-neoplastic elements, although we performed RT-PCR by extracting RNAs from which paired normal tissues were available, and obtained negative results.
In some tumors, putative cause-effect relationships between the histological type and E-cadherin inactivation by mutation or promoter hypermethylation have been proposed (Berx et al., 1995; Machado et al., 1999; Saito et al., 2001) . We therefore examined silencing of the E-cadherin gene by genetic and epigenetic changes as a potential mechanism for its inactivation in SS. Ecadherin missense mutation was detected in five cases of SS leading to the inactivation of the E-cadherin gene and resulting in the monophasic histology. E-cadherin promoter methylation was observed in five cases (12.5%) in SS, but in only one of which E-cadherin expression was silenced. Of four SS cases with Ecadherin mRNA expression in spite of E-cadherin promoter methylation, two were monophasic and another two were biphasic tumors. Our finding of unmethylated bands in all of the samples with promoter methylation of the E-cadherin gene (Figure 2 ) raises the possibility that the methylation status of E-cadherin might be heterogeneous within individual monophasic tumors. Alternatively, methylation status might be different in the different cell types (spindle cells, epithelial cells) in biphasic tumors.
In addition to silencing by genetic and epigenetic changes, transcriptional repression has emerged as another mechanism of downregulation of E-cadherin expression. The transcription factor Snail has been shown to be expressed by fibroblasts and some epithelial tumor cells, and in turn blocks E-cadherin gene expression by binding directly to the E-boxes present on the proximal E-cadherin promoter (Batlle et al., 2000; Cano et al., 2000) . Although many studies have documented an inverse relationship between endogenous E-cadherin expression and endogenous Snail expression (Poser et al., 2001; Hajra et al., 2002; Nieto, 2002; Rosivatz et al., 2002; Thiery, 2002) , there are no published data in the field of sarcomas. In this study, we employed quantitative real-time PCR to examine the expression level of Snail transcription factor, because at present no antibodies are available for immunohistochemical analysis for this gene product. We found statistically lower expression of Snail in SS with Ecadherin mRNA expression compared to those without. The data are consistent with transcriptional repression of E-cadherin by Snail in SS, but this remains to be confirmed at the functional level. E-cadherin expression may be regulated by molecular switching through Snail, directing the differentiation of SS tumor cells to an epithelial phenotype. It should also be noted that it is Figure 4 Scattergram of ELF3 mRNA expression levels in SS according to histology (biphasic vs monophasic). The value of ELF3 mRNA expression was standardized to that of TBP mRNA expression. ELF3 mRNA level in biphasic SS was significantly higher than those of monophasic tumors (P ¼ 0.04, Mann-Whitney U-test) E-cadherin inactivation in synovial sarcomas T Saito et al equally plausible that this inverse correlation between Ecadherin and Snail in SS is indirect (i.e. SS tumor cells with epithelial characteristics will tend to express reduced levels of mesenchymal-associated proteins such as Snail). Another possible level of control of E-cadherin expression is through chromatin-mediated effects such as chromatin modification and chromatin remodeling (Brown, 2003) .
Another correlate of the epithelial morphology in SS cells is SYT-SSX fusion type. It is tempting to speculate that target genes of the SYT-SSX protein, which is thought to function as an aberrant transcriptional regulator, are associated with epithelial differentiation, because the SYT-SSX2 fusion is almost exclusively found in monophasic SS, whereas biphasic SS usually contain the SYT-SSX1 fusion (Kawai et al., 1998; Antonescu et al., 2000; Ladanyi et al., 2002) . Recent microarray-based expression profiling studies of SS have identified genes that appear differently expressed between SS and other SCS or monophasic and biphasic histology (Allander et al., 2002; Nagayama et al., 2002; Nielsen et al., 2002; Lee et al., 2003; Segal et al., 2003) . ELF3, for example, was identified as one of the genes differentially overexpressed in biphasic cases, compared to monophasic tumors (Allander et al., 2002) . We therefore compared E-cadherin expression and ELF3 transcript levels with the SYT-SSX fusion type, to evaluate them as potential epithelial-specific downstream target genes of SYT-SSX. However, there was no relationship between their expression at the mRNA level and SYT-SSX fusion type. The meaning of ELF3 expression in SS is currently unknown, but its higher expression level in biphasic SS suggests some role in epithelial glandular differentiation. However, it is of interest to note that all SS cases with E-cadherin missense mutations contained the SYT-SSX1 fusion, and this association was marginally statistically significant. This finding might provide a key to the question as to why SS with the SYT-SSX1 fusion can show either a monophasic or biphasic phenotype.
The morphological transitions of SS cells are reminiscent of epithelial-mesenchymal transitions in other biological systems. It is unclear whether the loss of Ecadherin expression is a passive result of differentiation or whether it might play a more causative role in the differentiation of spindle cell morphology in SS. A previous report illustrated that disruption of E-cadherin function in mammalian epiblast cells at the primitive streak in vitro caused the cells to acquire phenotypic characteristics of the mesoderm (fibroblastic morphology) (Burdsal et al., 1993) . The inverse correlation between Snail and E-cadherin suggests the possibility of transcriptional repression of E-cadherin by Snail in SS, as has been shown in epithelial malignancies. In addition, it has been also shown that the epithelialmesenchymal transition can indeed be a reversible process, and that it occurs several times during embryonic development (Nieto et al., 1994; Sefton et al., 1998; Auersperg et al., 1999; Cheng et al., 2001) . In fact, E-cadherin re-expression has been found to occur in the metastatic process where the migratory cells need to establish attachment to their destination tissue Bukholm et al., 2000; Graff et al., 2000) . These findings may suggest that the loss of Ecadherin expression plays a causative role in the acquisition of spindle cell morphology in SS, being in agreement with the previous finding of mutational inactivation of E-cadherin gene in some cases of monophasic SS (Saito et al., 2001) . Taken into account the present E-cadherin data, we propose a model of morphologic differentiation in SS ( Figure 5 ). In spite of still poorly understood differences in the transcriptional targets of SYT-SSX1 and SYT-SSX2, SS cases with the SYT-SSX1 fusion transcript have a greater likelihood of epithelial differentiation. However, some SS cases with the SYT-SSX1 fusion transcript escape epithelial differentiation by downregulating E-cadherin either by Snailmediated transcriptional repression or through Ecadherin inactivating mutations. Among biphasic SS, additional events may be necessary for SS tumor cells with E-cadherin protein expression to show glandular differentiation. An example of this may be the remodeling of the extracellular matrix (Saito et al., 2002b) . Recently, Slug, ZEB1, SIP1 (ZEB2) and E12/47 were also found to downregulate E-cadherin expression through direct binding to single or paired E-boxes (Comijn et al., 2001; Perez-Moreno et al., 2001; Guaita et al., 2002; Bolos et al., 2003) . Therefore, the possibility remains that downregulation of E-cadherin occurs via these non-Snail-related silencers. Furthermore, we should note that overactivity or overexpression of transcription factors positively mediating epithelial differentiation might also play a role in glandular epithelial differentiation in SS.
Finally, we should briefly discuss the conflicting data regarding clinical behavior and E-cadherin expression and SYT-SSX fusion type in SS. It is described that patients with SYT-SSX1 tumors present more often with metastatic disease and poor clinical course (Kawai et al., 1998; Ladanyi et al., 2002) , whereas we reported
SYT-SSX1
Transcriptional targets SYT-SSX2 Figure 5 Proposed model of epithelial differentiation pathways in SS. Owing to putative subtle differences in transcriptional targets of SYT-SSX1 and SYT-SSX2, SS cases with the SYT-SSX1 fusion protein may have a greater propensity or potential for epithelial differentiation. Some SS cases with the SYT-SSX1 fusion transcript may escape epithelial differentiation by downregulating E-cadherin either by Snail-mediated transcriptional repression or through Ecadherin inactivating mutations. The thickness of the arrows is proportional to the percentage of cases in each pathway favorable survival rate in patients with preserved Ecadherin expression (Saito et al., 2000) . Actually, almost all biphasic tumors that tend to show preserved Ecadherin expression are known to have SYT-SXX1 fusion transcript, although data on fusion type were not available in all of our original cases (Saito et al., 2000) . We confirmed this correlation between SYT-SSX fusion type and E-cadherin membranous expression in the present study. The aforementioned discrepancy may be explained by the fact that biphasic histology had a statistically significant favorable prognostic impact in the series from Kyushu University after further followup (P ¼ 0.02) (Saito et al., unpublished data) . The impact of monophasic vs biphasic histology on survival is known to be inconsistent among different prognostic analyses (Kawai et al., 1998; Machen et al., 1999; Lewis et al., 2000; Trassard et al., 2001) . This might affect the significance of E-cadherin expression on survival rate in our previous report where the significance of E-cadherin expression disappeared by multivariate analysis (Saito et al., 2000) .
In conclusion, we report here that E-cadherin mRNA expression in SS is associated with reduced Snail expression level, consistent with the possibility of the transcriptional repression of E-cadherin by Snail in SS. Hypermethylation of the promoter region of the Ecadherin gene and E-cadherin missense mutation were observed equally in 12.5% of SS, and the latter being found only in monophasic tumors with SYT-SSX1 fusion gene. These results indicate that the possible regulation of E-cadherin expression by Snail as well as its silencing by E-cadherin missense mutation may have an important role in understanding the phenotypic heterogeneity of SS.
Materials and methods
Tumor samples
Snap-frozen tumor samples from 20 cases of SS were obtained from a collection of soft-tissue tumors registered in the Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences Kyushu University, Japan. Fresh tumor samples were carefully dissected in order not to include the surrounding normal tissue, and the samples were frozen in liquid nitrogen immediately and stored at À801C. In addition, 20 frozen samples of SS were obtained from Department of Pathology, Memorial Sloan-Kettering Cancer Center (MSKCC), NY, USA under a protocol approved by the MSKCC Institutional Review Board. Diagnosis in each case was based on conventional light microscopic examination and molecular detection of SYT-SSX fusion gene by RT-PCR, and finally 40 cases of SS were prepared. Some of the SS cases used in this study were the same as in our previous study (Saito et al., 2001) except one case in which the SYT-SSX fusion transcript could not be detected by RT-PCR, which was therefore excluded from the present study. Histological subclassification of SS was made according to the presence of an epithelial glandular component. Of the 40 cases, 30 were thus classified as monophasic, nine were classified as biphasic, and the single remaining case was classified as a poorly differentiated SS. A poorly differentiated SS was included within the monophasic group for statistical analysis. All of the SS cases were analysed for SYT-SSX fusion type using previously described specific primers (Kawai et al., 1998) , and thereby confirmed to have either SYT-SSX1 or SYT-SSX2.
RT-PCR for E-cadherin and ELF3
Total RNA was extracted using TRIZOL Reagent (GIBCO BRL, Tokyo, Japan) according to the manufacturer's protocol. In all, 5 mg of RNA from each sample was used for the subsequent reverse transcription. After the reaction, RNase treatment was performed to eliminate RNA. Sequences of specific pairs of primers were as follows: E-cadherin (upper primer: 5 0 -GAC GCG GAC GAT GAT GTG AAC-3 0 ; lower primer: 5 0 -TTG TAC GTG GTG GGA TTG AAG A-3 0 ), ELF3 (upper primer: 5 0 -CTG AGC AAA GAG TAC TGG GAC TGT C-3 0 ; lower primer: 5 0 -CCA TAG TTG GGC CAC AGC CTC GGA GC) and b-actin (upper primer: 5 0 -AGG CCA ACC GCG AGA AGA TGA CC-3 0 ; lower primer: 5 0 -GAA GTC CAG GGC GAC GTA GCAC-3 0 ). Each PCR product was obtained after 40 cycles of amplification with an annealing temperature of 56.31C. The PCR products were electrophoresed on a 2.0% agarose gel and visualized with ethidium bromide.
Polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) and mutational analysis of E-cadherin gene Genomic DNA was extracted from each frozen specimen as previously described (Saito et al., 2002a) . Some of the mutational analyses of E-cadherin in SS were previously performed (Saito et al., 2001) . Six sets of intronic primers were used for genomic DNA screening of the E-cadherin gene from exon 4 to exon 9. The primer sequences were the same as those aforementioned (Berx et al., 1995; Saito et al., 1999) . PCR and subsequent SSCP were carried out as described previously (Saito et al., 2001 ).
Methylation-specific PCR (MSP) analysis of the promoter region of the E-cadherin gene
Bisulfite conversion was performed with 1 mg of genomic DNA, using the reagents provided in the CpGenome DNA modification Kit (Intergen, NY, USA). This process converts unmethylated cytosine residues to uracil, whereas methylated cytosine residues remain unchanged. MSP was performed to determine the DNA methylation status of CpG islands of the promoter region of the E-cadherin gene. MSP is based on the principle that the DNA sequences of methylated and unmethylated genomic regions differ after bisulfite conversion, and are thus distinguishable by sequence-specific PCR primers (Herman et al., 1996) . The two pairs of primers (Islands 1 and 3) used in this study were as previously described (Graff et al., 1997) .
Quantitative TaqMan-based RT-PCR analysis of Snail expression
Real-time quantitative RT-PCR for Snail (GenBank: NM005985) mRNA level was also performed for each sample using an ABI PRISM 7700 Sequence Detection System (Applied Biosystems). Oligonucleotide primers and TaqMan probes were designed as follows: forward primer, 5 0 -ACCAC-TATGCCGCGCTCTT-3 0 , reverse primer, 5 0 -GGTCGTAGG GCTGCTGGAA-3 0 , and probe, 5 0 -FAM (6-carboxy-fluorescein)-TCGTCAGGAAGCCCTCCGACCC-TAMRA (6-carboxy-tetramethyl-rhodamine)-3 0 (Sugimachi et al., 2003 ).
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Each primer was placed on a different exon to avoid amplification of contaminating genomic DNA. A set of primers and probe for the internal housekeeping gene, glyceraldehyde-3-phosphatase dehydrogenase (GAPDH) (TaqMan GAPDH control reagent kit) was purchased from Perkin-Elmer Applied Biosystems. For the construction of the standard curve, a serial 1 : 10 dilution of plasmid DNA containing each target cDNA was analysed, and copy numbers of the target cDNA were estimated by standard curves. All the reactions for standard samples and samples of patients were performed in triplicate, and the data were averaged from the values obtained in each reaction. The obtained data were standardized by using data from the internal housekeeping gene, GAPDH.
Immunohistochemistry for E-cadherin
Formalin-fixed, paraffin-embedded tissue sections from 40 SS cases corresponding to those from which RNA was extracted were processed for immunohistochemical staining using a primary monoclonal antibody against E-cadherin (diluted at 1 : 1000; Transduction Laboratories), as described previously (Saito et al., 2000) . Subcellular localization (membrane, cytoplasm, or nuclear) was also noted.
Quantitative TaqMan-based RT-PCR analysis of ELF3 expression
To validate our previous microarray result (Allander et al., 2002) , a separate set of 73 cases of SS was prepared from the Department of Pathology, MSKCC, NY, USA under a protocol approved by the MSKCC Institutional Review Board. This subset contained 54 of monophasic tumors and 19 of biphasic tumors. Real-time PCR for ELF3 was performed using iCycler (BioRad, USA). The quantity of ELF3 expression was normalized by using TATA-box binding protein (TBP) as an endogenous control gene. The sequences for primers and probes used were as follows: ELF3-FP, 5 0 -GCATATTTTCTTGCTGCCAGTCT-3 0 ; ELF3-RP, 5 0 -ACC ACGGCACTGATTTTCAGTT-3 0 ; ELF3-probe, 5 0 -ACTGT TCTTCACTCTCTTGGCTCCTGTGCA-3 0 , TBP-FP, 5 0 -GC ATATTTTCTTGCTGCCAGTCT-3 0 ; TBP-RP, 5 0 -ACCACG GCACTGATTTTCAGTT-3 0 ; TBP-probe, 5 0 -ACTGTTCTT-CACTCTCTTGGCTCCTGTGCA-3 0 . Standard plasmids were generated by cloning cDNA fragments of ELF3 and TBP into the pCRII TOPO plasmid (Invitrogen).
Statistical analysis
The w 2 test was used to assess the correlation between various parameters. A two-tailed P-value less than 0.05 by Fisher's exact test was considered as significant. Comparison between the Snail mRNA expression level and E-cadherin expression was evaluated using Mann-Whitney U-test. A P-value o0.05 was considered to be statistically significant.
